Haemophilia A Clinical Trials

99 clinical trials for Haemophilia A across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Prevention of bleeding in haemophilia A by prophylactic treatment with Nuwiq® — RECRUITING
• A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A — RECRUITING · PHASE1
• Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®) — RECRUITING
• A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A — RECRUITING · PHASE3
• Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa — RECRUITING · PHASE3
• Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors — RECRUITING
• Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients — RECRUITING
• A multinational, prospective, open-label, roll-over study (LIBERTY) to provide post-trial access to treatment for patients with haemophilia A who have completed a previous trial with efanesoctocog alfa — RECRUITING · PHASE3
• A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI — RECRUITING
• Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients. — RECRUITING · PHASE3
• A Study Following Males With Haemophilia A on Prophylaxis With Esperoct® — RECRUITING
• Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol — RECRUITING
• An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct — RECRUITING
• Prevalence of Synovitis in Patients With Haemophilia A — RECRUITING
• Efficacy and safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in previously treated Chinese patients with haemophilia A — OTHER · PHASE3
• A Multi-Centre, Open-Label, Non-Controlled Trial on Safety and Efficacy of N8 in Prevention and Treatment of Bleeds in Previously Treated Subjects with Haemophilia A Sub-Trial: Safety and Efficacy of N8 in Prevention and Treatment of Bleeding during Surgical Procedures in Subjects with Haemophilia A — COMPLETED · PHASE3
• A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients with Severe Haemophilia A — COMPLETED · PHASE3
• A Safety and Efficacy study of GreenGene™ F in Patients Diagnosed with Severe Hemophilia A who have previously completed another study with GreenGene™ F — TERMINATED · PHASE3
• An Investigator-sponsored study on rFVIIa prophylaxis in children with haemophilia A and inhibitors Estudio promovido por el investigador sobre profilaxis con rFVIIa en niños con hemofilia A e inhibidores — TERMINATED · PHASE2
• A STUDY ON FACTOR VIII CONCENTRATE USED BY CONTINUOUS INFUSION IN PATIENTS WITH INHERITED FACTOR VIII DEFICIENCY DURING SURGERY — COMPLETED · PHASE3
• Research study to look at side effects during regular injection with factor VIII medicine named turoctocog alfa for a 8 weeks period — OTHER · PHASE4
• Evaluation of safety following Immune Tolerance Induction treatment with turoctocog alfa in patients with haemophilia A following inhibitor development in NN7170-4213 trial — COMPLETED · PHASE3
• A 12-month, interventional, open-label, phase 4 study in Europe (SHINE) to investigate the course of synovial hypertrophy as detected by joint ultrasound and MRI in patients with haemophilia A on efanesoctocog alfa prophylaxis. — TERMINATED · PHASE4
• Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients — COMPLETED
• A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy People — COMPLETED · PHASE1
• Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany — NOT_YET_RECRUITING
• Post-Marketing Surveillance (Use-results Surveillance) With Esperoct® — COMPLETED
• Pharmacokinetic comparison of efanesoctocog alfa vs other EHL-rFVIII products in participants with severe haemophilia A — OTHER · PHASE1
• A low-interventional study to evaluate long-term effectiveness of real-world prophylactic treatment with efanesoctocog alfa on joint health in people with haemophilia A (ALTITUDE) — TERMINATED · PHASE4
• A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis — ACTIVE_NOT_RECRUITING · PHASE4
• A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy Men — COMPLETED · PHASE1
• Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10) — COMPLETED · PHASE3
• Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A — COMPLETED · PHASE3
• A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5) — COMPLETED · PHASE3
• A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors — COMPLETED · PHASE3
• MOdern Treatment of Inhibitor-PositiVe PATiEnts with Haemophilia A – An International Low-Interventional Pragmatic Investigator Initiated Trial — TERMINATED · PHASE4
• A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and Cartridge — COMPLETED · PHASE1
• Register of Patients With haEmophilia A tReated With Afstyla® — COMPLETED
• A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B — COMPLETED
• An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment — COMPLETED
• Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B — COMPLETED
• BAY81-8973 Pediatric Safety and Efficacy Trial — COMPLETED · PHASE3
• Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities — COMPLETED
• A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A — COMPLETED · PHASE3
• A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6) — COMPLETED
• A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors — COMPLETED · PHASE2
• Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients — COMPLETED
• To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan — COMPLETED
• Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A — TERMINATED · PHASE4
• Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A — COMPLETED · PHASE3

Refine this search